← Leaderboards
Neal L Weintraub
Augusta University
$17,807,491
Attributed
$23,850,337
Total exposure
14
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,850,337 · 14
By mechanism
R01$18,852,875 · 9
P01$3,486,801 · 3
R56$1,510,330 · 1
M01$331 · 1
Top collaborators
- Muhammad Ashraf9 shared
- Yao Liang Tang9 shared
- Xin-Yun Lu8 shared
Most similar at Augusta University
Same institution · by research overlap
- Xin-Yun Lu$15,785,318
- Ruth B. Caldwell$11,181,117
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposPlayMediatingCellsInflammationSignal TransductionOverexpressionTissuesProteinsBlood VesselsMolecularKnockout MiceInflammatoryAtherosclerosisInsightOxidative StressBasePathogenesisLinkAngiotensin IiImpairmentInhibitor/AntagonistGenesInfusion Procedures
Grant awards (56)
DARC, Inflammaging and Alzheimer's Disease$741,989
R01 · FY2025 · AG
Neuronal HDAC9, Synaptic Plasticity and Alzheimer's Disease$556,262
R01 · FY2025 · AG
DARC, Inflammaging and Alzheimer's Disease$757,132
R01 · FY2024 · AG
Neuronal HDAC9, Synaptic Plasticity and Alzheimer's Disease$567,615
R01 · FY2024 · AG
Neuronal HDAC9, Synaptic Plasticity and Alzheimer's Disease$567,615
R01 · FY2023 · AG
Neuronal HDAC9, Synaptic Plasticity and Alzheimer's Disease$567,615
R01 · FY2022 · AG
Mechanisms of myeloperoxidase and Nox4 interactions in abdominal aortic aneurysm$527,553
R01 · FY2021 · HL · contact PI
Innovative Approaches to Treat Duchenne Muscular Dystrophy Using iPSC-Derived Muscle Progenitors$499,954
R01 · FY2021 · AR
HDAC9, Aging and Alzheimer's Disease$762,845
R56 · FY2020 · AG
Notch1/miR-322 Axis in Stem Cell Mediated Vascular Repair$621,413
R01 · FY2020 · HL
Mechanisms of myeloperoxidase and Nox4 interactions in abdominal aortic aneurysm$526,697
R01 · FY2020 · HL · contact PI
Innovative Approaches to Treat Duchenne Muscular Dystrophy Using iPSC-Derived Muscle Progenitors$515,417
R01 · FY2020 · AR
HDAC9, Aging and Alzheimer's Disease$747,485
R56 · FY2019 · AG
Notch1/miR-322 Axis in Stem Cell Mediated Vascular Repair$621,413
R01 · FY2019 · HL
Mechanisms of myeloperoxidase and Nox4 interactions in abdominal aortic aneurysm$522,415
R01 · FY2019 · HL · contact PI
Epigenetic regulation of HDAC9 in obesity and atherosclerosis$438,310
R01 · FY2019 · HL · contact PI
Innovative Approaches to Treat Duchenne Muscular Dystrophy Using iPSC-Derived Muscle Progenitors$528,617
R01 · FY2018 · AR
Mechanisms of myeloperoxidase and Nox4 interactions in abdominal aortic aneurysm$522,129
R01 · FY2018 · HL · contact PI
Epigenetic regulation of HDAC9 in obesity and atherosclerosis$438,310
R01 · FY2018 · HL · contact PI
Notch1/miR-322 Axis in Stem Cell Mediated Vascular Repair$621,413
R01 · FY2017 · HL
Innovative Approaches to Treat Duchenne Muscular Dystrophy Using iPSC-Derived Muscle Progenitors$541,817
R01 · FY2017 · AR
Epigenetic regulation of HDAC9 in obesity and atherosclerosis$441,220
R01 · FY2017 · HL · contact PI
Notch1/miR-322 Axis in Stem Cell Mediated Vascular Repair$634,413
R01 · FY2016 · HL
Innovative Approaches to Treat Duchenne Muscular Dystrophy Using iPSC-Derived Muscle Progenitors$528,394
R01 · FY2016 · AR
Epigenetic regulation of HDAC9 in obesity and atherosclerosis$448,400
R01 · FY2016 · HL · contact PI
Perivascular adipose tissue and vascular remodeling$399,027
R01 · FY2016 · HL · contact PI
Perivascular adipose tissue and vascular remodeling$400,429
R01 · FY2015 · HL · contact PI
Perivascular adipose tissue and vascular remodeling$408,761
R01 · FY2014 · HL · contact PI
Perivascular adipose tissue and vascular remodeling$410,378
R01 · FY2013 · HL · contact PI
Angiotensin II, oxidative stress and aneurysm formation$191,780
R01 · FY2013 · HL · contact PI
Angiotensin II, oxidative stress and aneurysm formation$178,143
R01 · FY2013 · HL · contact PI
Perivascular adipose tissue and vascular remodeling$459,820
R01 · FY2012 · HL · contact PI
Angiotensin II, oxidative stress and aneurysm formation$388,575
R01 · FY2012 · HL · contact PI
Angiotensin II, oxidative stress and aneurysm formation$392,500
R01 · FY2011 · HL · contact PI
CD14, Surfactant Proteins, and Vascular Inflammation$401,067
P01 · FY2010 · HL · contact PI
Angiotensin II, oxidative stress and aneurysm formation$392,500
R01 · FY2010 · HL · contact PI
CD14, Surfactant Proteins, and Vascular Inflammation$392,322
P01 · FY2009 · HL · contact PI
CD14, Surfactant Proteins, and Vascular Inflammation$379,976
P01 · FY2008 · HL · contact PI
Angiotensin II, oxidative stress, and aneurysm formation$369,790
R01 · FY2008 · HL · contact PI
CD14, Surfactant Proteins, and Vascular Inflammation$381,840
P01 · FY2007 · HL · contact PI
Angiotensin II, oxidative stress, and aneurysm formation$369,790
R01 · FY2007 · HL · contact PI
Angiotensin II, oxidative stress, and aneurysm formation$360,084
R01 · FY2006 · HL · contact PI
CD14, Surfactant Proteins, and Vascular Inflammation$339,388
P01 · FY2006 · HL · contact PI
Endotoxin, Vascular Inflammation and Atherosclerosis$209,695
R01 · FY2006 · HL · contact PI
Endotoxin, Vascular Inflammation and Atherosclerosis$42,365
R01 · FY2006 · HL · contact PI
OXIDATIVE STRESS IN AORTIC ANEURYSM$331
M01 · FY2006 · RR · contact PI
Angiotensin II, oxidative stress, and aneurysm formation$368,750
R01 · FY2005 · HL
Endotoxin, Vascular Inflammation and Atherosclerosis$258,125
R01 · FY2005 · HL
Endotoxin, Vascular Inflammation and Atherosclerosis$258,125
R01 · FY2004 · HL
Endotoxin, Vascular Inflammation and Atherosclerosis$258,125
R01 · FY2003 · HL
Reactive oxygen species in smooth muscle growth$354,303
P01 · FY2002 · HL
Reactive oxygen species in smooth muscle growth$354,303
P01 · FY2001 · HL
EPOXYEICOSATRIENOIC ACIDS IN THE CORONARY CIRCULATION$73,467
P01 · FY2001 · HL
Reactive oxygen species in smooth muscle growth$354,303
P01 · FY2000 · HL
EPOXYEICOSATRIENOIC ACIDS IN THE CORONARY CIRCULATION$227,916
P01 · FY2000 · HL
EPOXYEICOSATRIENOIC ACIDS IN THE CORONARY CIRCULATION$227,916
P01 · FY2000 · HL